Literature DB >> 28360774

Leukocytosis after Clozapine Treatment in a Patient with Chronic Schizophrenia.

Aslıhan Polat1, Uğur Çakir2, Nermin Gündüz1.   

Abstract

Clozapine is an atypical antipsychotic drug that is approved by the US Food and Drug Administration (FDA) for the treatment of psychotic disorders. Agranulocytosis is a well-established side effect of clozapine; clozapine has also been associated with other blood dyscrasias like leukocytosis, albeit rarely. In this paper, we aim to report a case of possible clozapine-associated leukocytosis in a 41-year-old woman.

Entities:  

Keywords:  Antipsychotics; clozapine; hematological; leukocytosis

Year:  2016        PMID： 28360774      PMCID： PMC5353246          DOI： 10.5152/npa.2015.9855

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN： 1300-0667            Impact factor:   1.339


  11 in total

1.  Clozapine-induced blood dyscrasias.

Authors:  E D Trinidad; A Potti; S A Mehdi
Journal:  Haematologica       Date:  2000       Impact factor: 9.941

2.  Chronic leukocytosis associated with clozapine treatment.

Authors:  Michael A Sopko; Charles F Caley
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

3.  Chronic leukocytosis associated with clozapine: a case series.

Authors:  Subramoniam Madhusoodanan; Louis Cuni; Ronald Brenner; Martha Sajatovic; Nikhil Palekar; Dinara Amanbekova
Journal:  J Clin Psychiatry       Date:  2007-03       Impact factor: 4.384

4.  Clozapine and leukocytosis.

Authors:  A Popli; R Pies
Journal:  J Clin Psychopharmacol       Date:  1995-08       Impact factor: 3.153

5.  Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.

Authors:  Guido Bondolfi; Françoise Morel; Séverine Crettol; Fady Rachid; Pierre Baumann; Chin B Eap
Journal:  Ther Drug Monit       Date:  2005-08       Impact factor: 3.681

6.  Clozapine--deciphering the risks.

Authors:  S L Gerson
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

7.  Chronic leukocytosis and neutrophilia caused by rehabilitation stress in a clozapine-treated patient.

Authors:  E Seifritz; U Hemmeter; E Holsboer-Trachsler; W Pöldinger
Journal:  Pharmacopsychiatry       Date:  1993-05       Impact factor: 5.788

8.  Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients.

Authors:  Karin Fehsel; Stefan Loeffler; Klaus Krieger; Uwe Henning; Markus Agelink; Victoria Kolb-Bachofen; Ansgar Klimke
Journal:  J Clin Psychopharmacol       Date:  2005-10       Impact factor: 3.153

9.  Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.

Authors:  Juan Antonio Carrillo; Angustias G Herráiz; Sara Isabel Ramos; Guillermo Gervasini; Sonia Vizcaíno; Julio Benítez
Journal:  J Clin Psychopharmacol       Date:  2003-04       Impact factor: 3.153

10.  Lithium carbonate and leukocytosis.

Authors:  G Lapierre; R B Stewart
Journal:  Am J Hosp Pharm       Date:  1980-11
View more
  1 in total

1.  COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis.

Authors:  Mohapradeep Mohan; Benjamin Ian Perry; Ponnusamy Saravanan; Swaran Preet Singh
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.